Overview

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Status:
Completed
Trial end date:
2001-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus peripheral stem cell transplantation in treating women who have metastatic breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Hackensack Meridian Health
Hackensack University Medical Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Anastrozole
Carboplatin
Cyclophosphamide
Docetaxel
Doxorubicin
Etoposide
Liposomal doxorubicin
Pamidronate
Thiotepa